Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies
Bird P, Mease PJ, Deodhar A, Dougados M, Dubreuil M, Magrey M, Marzo-Ortega H, Rudwaleit M, de la Loge C, Ellis A, Fleurinck C, et al. (2023)
Internal Medicine Journal 53(S2): 24-25.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Bird, Paul;
Mease, Philip J.;
Deodhar, Atul;
Dougados, Maxime;
Dubreuil, Maureen;
Magrey, Marina;
Marzo-Ortega, Helena;
Rudwaleit, MartinUniBi;
de la Loge, Christine;
Ellis, Alicia;
Fleurinck, Carmen;
Oortgiesen, Marga
Alle
Alle
Einrichtung
Erscheinungsjahr
2023
Serien- oder Zeitschriftentitel
Internal Medicine Journal
Band
53
Ausgabe
S2
Seite(n)
24-25
Konferenz
IMSANZ 2023 Conference
Konferenzort
Cairns
Konferenzdatum
2023-09-06 – 2023-09-09
ISSN
1444-0903
eISSN
1445-5994
Page URI
https://pub.uni-bielefeld.de/record/2982796
Zitieren
Bird P, Mease PJ, Deodhar A, et al. Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies. Internal Medicine Journal. 2023;53(S2):24-25.
Bird, P., Mease, P. J., Deodhar, A., Dougados, M., Dubreuil, M., Magrey, M., Marzo-Ortega, H., et al. (2023). Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies. Internal Medicine Journal, 53(S2), 24-25.
Bird, Paul, Mease, Philip J., Deodhar, Atul, Dougados, Maxime, Dubreuil, Maureen, Magrey, Marina, Marzo-Ortega, Helena, et al. 2023. “Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies”, Internal Medicine Journal, 53 (S2): 24-25.
Bird, P., Mease, P. J., Deodhar, A., Dougados, M., Dubreuil, M., Magrey, M., Marzo-Ortega, H., Rudwaleit, M., de la Loge, C., Ellis, A., et al. (2023). Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies. Internal Medicine Journal 53, 24-25.
Bird, P., et al., 2023. Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies. Internal Medicine Journal, 53(S2), p 24-25.
P. Bird, et al., “Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies”, Internal Medicine Journal, vol. 53, 2023, pp. 24-25.
Bird, P., Mease, P.J., Deodhar, A., Dougados, M., Dubreuil, M., Magrey, M., Marzo-Ortega, H., Rudwaleit, M., de la Loge, C., Ellis, A., Fleurinck, C., Oortgiesen, M., Taieb, V., Gensler, L.S.: Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies. Internal Medicine Journal. 53, 24-25 (2023).
Bird, Paul, Mease, Philip J., Deodhar, Atul, Dougados, Maxime, Dubreuil, Maureen, Magrey, Marina, Marzo-Ortega, Helena, Rudwaleit, Martin, de la Loge, Christine, Ellis, Alicia, Fleurinck, Carmen, Oortgiesen, Marga, Taieb, Vanessa, and Gensler, Lianne S. “Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies”. Internal Medicine Journal 53.S2 (2023): 24-25.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar